Clinical Trial Update: Evaluate the Efficacy, Safety and Tolerability of Fecal Microbiota Transfer for the Treatment of Patients With Nonalcoholic Steatohepatitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating fecal microbiota transfer for efficacy, safety, and tolerability in patients with nonalcoholic steatohepatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis

Drugs mentioned

• Fecal Microbiota Transfer (fecal microbiota transplantation)

Snippet

Sponsor: Instituto de Investigación Marqués de Valdecilla | Conditions: Patients With Nonalcoholic Steatohepatitis | Phase 2 | Status: UNKNOWN